Search
COVID-19 vaccines represent a step towards ending the pandemic and getting back to a sense of normalcy after enduring more than a year of isolation, social distancing, and other measures to control the spread of the coronavirus.
Learn how researchers are making better CAR T cells by taking a lesson from viruses.
Memorial Sloan Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.
There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study published in the October 14 issue of the Journal of the American Medical Association, a theme issue on surgical care, found that breast-conserving surgery was presented and provided in the majority of patients evaluated.
A new study by investigators at Memorial Sloan Kettering Cancer Center (MSK) found no evidence of an increased risk of biochemical recurrence with any PDE5 inhibitor use or duration in the first year following radical prostatectomy.
An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.
The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer.
Learn why a new finding suggests that men with advanced prostate cancer should be screened for gene mutations.